Related Experiment Video
Updated: Nov 22, 2025
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
1Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa. anelisa.jaca@mrc.ac.za.
Insights
Omega-3 fatty acids, including long-chain (LCn3) and alpha-linolenic acid (ALA), show little to no effect on cardiovascular disease (CVD) mortality. However, ALA may slightly reduce the risk of CVD events and arrhythmias.
Area of Science:
- Cardiovascular Science
- Nutritional Science
- Public Health
Background:
- Cardiovascular diseases (CVDs) are a leading cause of death globally, particularly in low- and middle-income countries.
- In South Africa, CVD is the second leading cause of death, with risk factors including poor diet, hypertension, and diabetes.
- Omega-3 fatty acids are investigated for their potential cardioprotective effects.
Purpose of the Study:
- To assess the impact of increased fish and plant-based omega-3 fatty acid intake on CVD mortality and events.
- To evaluate the effectiveness of omega-3 interventions on primary, secondary, and tertiary health outcomes related to cardiovascular health.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) lasting at least 12 months.
- Inclusion of adult participants (≥18 years) at any CVD risk, receiving omega-3 supplements and dietary advice.
- Comparison against usual diet, placebo, or lower-dose omega-3 interventions, assessing various CVD-related outcomes.
Main Results:
- Increased intake of long-chain omega-3 fatty acids (LCn3) or alpha-linolenic acid (ALA) likely has minimal to no impact on all-cause CVD or coronary heart disease mortality.
- Evidence for these effects on mortality was of moderate to high certainty.
- No significant reduction in overall mortality was observed with increased omega-3 intake.
Conclusions:
- Moderate- to high-certainty evidence suggests short-chain fatty acids and LCn3 have little effect on mortality or cardiovascular health.
- Omega-3 ALA supplementation demonstrated a slight reduction in the risk of cardiovascular events and arrhythmias.
- Dietary interventions focusing on omega-3s may offer nuanced benefits for specific cardiovascular outcomes.
Background:
Cardiovascular diseases (CVDs) are defined as conditions involving decreased blood flow to the heart that can lead to heart attacks, stroke or other disorders. CVDs are a common cause of death in low- and middle-income countries. In South Africa (SA) in particular, CVD is the leading cause of death after HIV/AIDS, responsible for 1 in 6 deaths. CVD risk factors include unhealthy diets, hypertension, obesity, high cholesterol levels and diabetes. Omega-3 fatty acids may have a protective role in the risk of developing heart disease.
Objectives:
To evaluate the consequences of an increased intake of fish and plant-based omega-3 fatty acids on the risk of CVD mortality and events.
Methods:
The inclusion criteria for this review were randomised controlled trials (RCTs) lasting at least 12 months, which investigated men and women aged ≥18 years. These participants had to be at any risk of CVD while receiving dietary supplements and an advised diet to promote the intake of omega-3. This diet included oily fish, fish oils and seeds rich in omega-3. Comparisons with the interventions included the participants' usual diet, no advice, no supplements, placebo or lower-dose omega-3. The review evaluated the effectiveness of these interventions on primary (e.g. CVD deaths and events), secondary (e.g. major adverse cerebrovascular or CVD events, body weight and other adiposity measures, and lipids) and tertiary (e.g. blood pressure and side-effects) outcomes.
Results:
Evidence from this review indicates that increasing the intake of long-chain omega-3 fatty acids (LCn3) or alpha-linolenic acid (ALA) probably has little or no effect on all-cause CVD or coronary heart disease mortality. Evidence was of moderate certainty, except for all-cause mortality, where there was a high certainty.
Conclusions:
According to moderate- to high-certainty evidence, short-chain fatty acids and LCn3 have little or no effect on mortality or cardiovascular health. However, omega-3 ALA slightly reduces the risk of CVD events and arrhythmias.
Related Concept Videos
01:26Atherosclerosis III: Management
03:38Structure of Lipids
01:26Coronary Artery Disease IV: Preventive Measures
01:18Lipids: Dietary Sources and Requirements
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:21Rheumatic Heart Disease III: Medical Management